Prostaglandins, Leukotrienes and Essential Fatty Acids
Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver
Introduction
Brain structure and function, particularly neurotransmission, depend on interactions between arachidonic acid (AA, 20:4n-6) and docosahexaenoic acid (DHA, 22:6n-3) at multiple target sites [1], [2], [3], [4], [5], [6]. These long-chain polyunsaturated fatty acids (PUFAs) and their respective shorter-chain PUFA precursors, linoleic acid (LA, 18:2n-6) and α-linolenic acid (α-LNA, 18:3n-3), are nutritionally essential and cannot be synthesized de novo in vertebrate tissue [7].
Animal studies with different proportions of PUFAs in the diet have identified broad dietary requirements for maintaining optimal brain function [8], and have demonstrated that metabolic and behavioral defects arise from severe long-term n-3 PUFA dietary deprivation. Additionally, clinical studies indicate that low dietary consumption of n-3 PUFAs or a low plasma DHA concentration is correlated with a number of brain diseases and with cognitive and behavioral defects in development and aging [9], [10], [11], and that dietary n-3 PUFA supplementation may be beneficial in some of these conditions [6], [12].
Effects on the brain of minor n-3 PUFA dietary deprivation associated with small declines in plasma DHA concentrations of the order found in human subjects have rarely been studied in animal models. Additionally, controversy exists about which dietary PUFA compositions are optimal for human brain function [6], [12], [13], [14], [15], [16]. The liver's in vivo capacity to convert α-LNA or eicosapentaenoic acid (EPA, 20:5n-3) to DHA, or LA to AA, has not be quantified in animals or in humans, although changes in this capacity with development, aging or disease likely impact brain PUFA metabolism [17], [18], [19], [20], [21].
Several important questions regarding the relation of brain PUFA metabolism to diet and liver PUFA metabolism have recently been partially resolved, and we shall discuss them in this brief review. These are: (1) What are the in vivo rates of brain consumption of AA and DHA in rats and humans? (2) How does brain DHA metabolism depend on dietary n-3 PUFA composition and the liver's ability to convert α-LNA to DHA? (3) How do brain lipid enzymes and trophic factors respond to dietary n-3 PUFA deprivation?
We have developed kinetic methods and models to address these questions in the intact awake organism. The methods include brain imaging with quantitative autoradiography or positron emission tomography (PET), intravenous injection of radiolabeled PUFAs to examine incorporation, turnover and synthesis rates of PUFAs in brain or liver, enzyme assays to evaluate lipid metabolizing enzymes, and molecular techniques to examine mRNA and protein levels of these enzymes.
Section snippets
Methods and models
AA and DHA are found in high concentrations in the stereospecifically numbered (sn)-2 position of brain membrane phospholipids, from where they can be released by selective phospholipase A2 (PLA2) enzymes [1], [22], [23], [24], [25], [26], [27]. After release, most of the unesterified AA or DHA will be rapidly reincorporated into an unesterified sn-2 position of a lysophospholipid via the acyl-CoA pool, through serial actions of an acyl-CoA synthetase and acyltransferase with the consumption of
Equations for incorporation rates and half-lives
We can quantify Jin for AA or DHA by infusing the albumin-bound radiolabeled PUFA intravenously, then imaging regional brain radioactivity in frozen coronal sections of brain, or determining radioactivity in individual stable lipids (phospholipids, triacylglycerols and cholesteryl esters) in high-energy microwaved brain [1], [37].
For imaging, we determine an incorporation coefficient k* (ml/s/g brain) using quantitative autoradiography or PET following the intravenous injection of the labeled
Conclusions
In this brief review, we have shown how radiotracer methods and kinetic models can be used to determine quantitative aspects of brain and liver metabolism of nutritionally essential PUFAs in the intact organism. We have presented experimentally determined regional and global brain AA and DHA consumption rates in humans and in unanesthetized rats. In the absence of dietary DHA, we conclude that a normal brain DHA content can be maintained by liver conversion of α-LNA to circulating DHA, provided
Acknowledgments
This work was supported by the Intramural Program of the National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. We thank Dr. Richard Bazinet for his helpful comments.
References (72)
- et al.
Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers
Trends Neurosci.
(1988) - et al.
Essential fatty acids and the brain: possible health implications
Int. J. Dev. Neurosci.
(2000) - et al.
The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats
J. Nutr.
(1989) - et al.
Polyunsaturated fatty acids in the food chain in the United States
Am. J. Clin. Nutr.
(2000) Commentary on the workshop statement. Essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids
Prostaglandins Leukot. Essent. Fatty Acids
(2000)- et al.
Delta-6 desaturation of alpha-linolenic acid in brain and liver during development and aging in the mouse
Neurosci. Lett.
(1992) - et al.
Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet
J. Lipid Res.
(2007) - et al.
A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP
Cell
(1991) Diversity of group types, regulation, and function of phospholipase A2
J. Biol. Chem.
(1994)- et al.
Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function
Prostaglandins Leukot. Essent. Fatty Acids
(2004)
A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis
Brain Res. Brain Res. Rev.
Delivery and turnover of plasma-derived essential PUFAs in mammalian brain
J. Lipid Res.
Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats
Biochim. Biophys. Acta
No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat
J. Lipid Res.
Brain incorporation of [1-11C]-arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography
Brain Res.
Lithium decreases turnover of arachidonate in several brain phospholipids
Neurosci. Lett.
Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography
Neuroimage
Low liver conversion rate of alpha-linolenic to docosahexaenoic acid in awake rats on a high-docosahexaenoate-containing diet
J. Lipid Res.
One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats
J. Lipid Res.
Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways
J. Biol. Chem.
Inflammatory processes in Alzheimer's disease
Prog. Neuropsychopharmacol. Biol. Psychiatry
Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats
J. Neurochem.
In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling
J. Mol. Neurosci.
Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues
Curr. Opin. Lipidol.
The role of dietary n-6 and n-3 fatty acids in the developing brain
Dev. Neurosci.
Control of polyunsaturated acids in tissue lipids
J. Am. Coll. Nutr.
Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment
Lipids
Cross-national comparisons of seafood consumption and rates of bipolar disorders
Am. J. Psychiatry
Alcohol consumption in rhesus monkeys depletes tissues of polyunsaturated fatty acids and alters essential fatty acid metabolism
Alcohol Clin. Exp. Res.
Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial
Arch. Gen. Psychiatry
Minister of National Health and Welfare
Sites of conditional essential fatty acid deficiency in end stage liver disease
J. Parenter. Enteral. Nutr.
Membrane docosahexaenoate is supplied to the developing brain and retina by the liver
Proc. Natl. Acad. Sci. USA
Rate of synthesis of docosahexaenoic acid from alpha-linolenic acid by rat brain is not altered by dietary N-3 polyunsaturated fatty acid deprivation
J. Lipid Res.
Preferential in vivo incorporation of [3H]arachidonic acid from blood in rat brain synaptosomal fractions before and after cholinergic stimulation
J. Neurochem.
Cited by (258)
Metabolic fate of DHA from regio- and stereospecific positions of triacylglycerols in a long-term feeding trial in rats
2023, Food Research InternationalDietary omega-3 fatty acid deficiency from pre-pregnancy to lactation affects expression of genes involved in hippocampal neurogenesis of the offspring
2023, Prostaglandins Leukotrienes and Essential Fatty AcidsThe role of nutrition in canine idiopathic epilepsy management: Fact or fiction?
2022, Veterinary JournalThe role of lipids in the brain
2022, Advances in Dietary Lipids and Human HealthMental health in society's margins: Poor n-3 PUFA intake and psychological well-being of homeless youth
2024, British Journal of NutritionMetabolomic Investigation of Brain and Liver in Rats Fed Docosahexaenoic Acid in Regio- and Enantiopure Triacylglycerols
2024, Molecular Nutrition and Food Research